Company profile of Shanghai Haohai Biotechnology Co., Ltd.

Shanghai Haohai Biotechnology Co., Ltd. (Haohai Biotechnology) is a high-tech biopharmaceutical company. The company has a registered capital of 120 million yuan and has an internationally competitive R&D, production, sales, investment platform and management team. Haohai Biotech's main business covers biological materials, biological preparations, and genetic engineering drugs.

Haohai Biotech has built a biopharmaceutical enterprise in Shanghai Songjiang Industrial Zone that complies with national GMP standards and has passed national ISO9001 quality control system certification. It is also preparing for EU CE and US FDA standard verification. Specializing in the production of a full range of degradable biomaterials sodium hyaluronate with broad clinical application prospects, water-soluble medical chitin and collagen series specialist products with independent intellectual property rights, as well as the national first-class new drug "gene recombinant human epidermal growth factor and Related products. The clinical applications of the products include ophthalmology, orthopedics, general surgery, obstetrics and gynecology, plastic surgery, burns, and dermatology.

Shanghai Qisheng Biological Products Co., Ltd. is a subsidiary of Haohai Biotech. It is a high-tech enterprise with strong technical force, advanced production equipment and excellent service quality, integrating the design, development, production and service of medical biomaterials. The company always adheres to the principle of "product quality first, company reputation first, With the purpose of "putting economic benefits first and serving users first" and the goal of "adding Qisheng's honor, building up its image, building its culture and strengthening its brand", we continue to strengthen the construction of corporate culture. The second generation of the company's main products Medical sodium hyaluronate, medical chitosan, medical collagen sponge, and Yansukang artificial tears series products are technologically equivalent to similar foreign products in the mid-to-late 1990s. They are in a leading position in the country, and their products are used in ophthalmic microsurgery, All products are of high clinical value in the treatment of joint disease, effective prevention of tissue adhesion after surgery, orthopedics, obstetrics and gynecology, hemostasis in various clinical departments, filling of trauma and defects, and eye care. All products are high-tech achievements in Shanghai. Transformation projects and national key new products have been included in the National Torch Plan Project and the Ministry of Health's 100 Promotion Projects in the Ten Years. The company's marketing network covers more than 20 provinces, cities and regions across the country, with annual sales exceeding 45 million yuan. It is a famous brand in Shanghai. The products "Qisheng" brand medical sodium hyaluronate and medical chitosan occupy 30% and 100% of the domestic market respectively.